SlideShare uma empresa Scribd logo
1 de 24
Early Detection  Of  Renal Disease
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Common clinical presentations of kidney disease
[object Object],[object Object],[object Object],Screening method ,[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],Screening method  Serum Creatinine
Relationship between  serum creatinine and GFR
1.23 x  (140-Age) x BW   Sr Cr (umol/l) 1.04 x  (140-Age) x BW   Sr Cr (umol/l) Estimated Glomerular Filtration rate Man Woman Screening method  Estimated GFR
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Screening methods  Urine testing
Screening methods  Microalbuminuria testing
[object Object],[object Object],Target groups for screening
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Screening renal disease The High Risk Groups
Screening of renal disease :  Hypertensive patients UFEME BUSE/Cr USS KUB Other test Young hypertensive Yearly Yearly UFEME BUSE/Cr All hypertensive Frequency Screening tests
[object Object],[object Object],[object Object],[object Object],When to screen Methods   Screening of renal disease  Diabetic Patients Type 1 Type 2 DM 5 years after diagnosis (age >12) Or earlier if CV risk yearly At diagnosis Frequency First screening
Urine dipstick for protein Positive (Urine protein >300mg/l) On 2 separate occasions (exclude other causes) Overt Nephropathy Quantify excretion rate 24HUP Negative Screen for Microalbuminuria (on early morning spot urine) Negative Yearly test Positive Retest twice in 3-6/12 Exclude other cause If 2 of test are positive Diagnosis of microalbuminuria  Is established  3-6 monthly follow-up of  microalbuminuria Optimise glycaemic control Strict Bp control ACE/ARB Stop smoking Lifestyle modification Treat hyperlipidaemia Avoid excessive protein intake Monitor renal function Monitor other endorgan damage Algorithm: Screening for proteinuria/microalbuminuria in DM
Proteinuria  is a major manifestation of renal disease Screening of renal disease Proteinuria <20 <30 Normoalbuminuria >35 women >25 men >200 >200 >300 Overt  Proteinuria 3.5-35 women 2.5-25 men 20-200 20-200 30-300 Microalbuminuria Urine Albumin:creatinine ratio (mg/mmol) Urine Albumin Concentration (mg/l) <3.5 women <2.5 men <20 First voided morning specimen Timed Collection (ug/min) 24 hr Collection (mg/24h) Specimen collected Albumin Excretion
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Causes of false positive proteinuria
[object Object],[object Object],[object Object],[object Object],Significance of Proteinuria
History Physical Examination Urine Examination of Urinary sediment Abnorma l refer to a nephrologist   Normal Repeat visit for a  Qualitative proteinuria test Positive Do Renal profile Quantitate urinary protein Refer to nephrologist Negative Transient proteinuria Reassure Evaluation of persistent proteinuria
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Screening of renal disease Hematuria
Detection of Microscopic hematuria >5RBC/hpf or +ve dipstik test ,[object Object],[object Object],[object Object],[object Object],[object Object],Urological referral ,[object Object],[object Object],[object Object],Diagnosis And Treatment ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],No diagnosis ,[object Object],[object Object],Evaluation of asymptomatic hematuria
[object Object],[object Object],Benefits of early detection a) specific disease treatment  e.g. immunosuppression b) future transplant –  timing, risk of recurrent disease etc c) counselling and screening of relatives
[object Object],[object Object],[object Object],Benefits of early detection ,[object Object],[object Object],[object Object]
[object Object],Benefits of early detection ,[object Object],[object Object],[object Object],[object Object],[object Object]
Studies on Early vs late referral AV access use at initiation of HD increased with earlier referral time 499 ER < 1 mo LR > 12 mo USA 1995-1998 CHOICE study LR > ER 78 106 ER > 3 mo LR < 1 mo Brazil 1992-1995 Sesso et al LR > ER 2264 ER > 4 mo LR < 4 mo Texas 2002 Stack et al LR > ER 325 325 ER > 4 mo LR < 4 mo Edinburgh 1987-1992 Eadington et al LR > ER 153 65 ER > 6 mo LR < 1 mo Paris 1989-1991 Jungers et al LR > ER 32 23 ER > 1 mo LR < 1 mo Oxford 1981 Ratcliffe et al Mortality risk Mean length of hospital stay (days) No of patients Timing of referral Location/ year Source
THANK  YOU

Mais conteúdo relacionado

Mais procurados

Anemia in Chronic Kidney DIsease
Anemia in Chronic Kidney DIseaseAnemia in Chronic Kidney DIsease
Anemia in Chronic Kidney DIseaseVishal Golay
 
Preparation for transplantation (mih)
Preparation for transplantation (mih)Preparation for transplantation (mih)
Preparation for transplantation (mih)FarragBahbah
 
Gout Summery Updated 2020 American College Of Rheumatology Guideline
Gout  Summery Updated 2020 American College Of Rheumatology Guideline Gout  Summery Updated 2020 American College Of Rheumatology Guideline
Gout Summery Updated 2020 American College Of Rheumatology Guideline Wafa sheikh
 
Hepatorenal syndrome
Hepatorenal syndromeHepatorenal syndrome
Hepatorenal syndromeheyraghul
 
parkinsons disease case presentation in Ayurveda
parkinsons disease case presentation in Ayurveda parkinsons disease case presentation in Ayurveda
parkinsons disease case presentation in Ayurveda Kamal Sharma
 
Benign Prostatic Hyperplasia (BPH and LUTS)
Benign Prostatic Hyperplasia (BPH and LUTS)Benign Prostatic Hyperplasia (BPH and LUTS)
Benign Prostatic Hyperplasia (BPH and LUTS)Abdullah Mohammad
 
CKD MBD - Think Outside The Box - Case Scenarios Snapshots - Dr. Gawad
CKD MBD - Think Outside The Box - Case Scenarios Snapshots  - Dr. GawadCKD MBD - Think Outside The Box - Case Scenarios Snapshots  - Dr. Gawad
CKD MBD - Think Outside The Box - Case Scenarios Snapshots - Dr. GawadNephroTube - Dr.Gawad
 
Physiological Principles of Hemodialysis - Solve the Crosswords - Dr. Gawad
Physiological Principles of Hemodialysis - Solve the Crosswords - Dr. GawadPhysiological Principles of Hemodialysis - Solve the Crosswords - Dr. Gawad
Physiological Principles of Hemodialysis - Solve the Crosswords - Dr. GawadNephroTube - Dr.Gawad
 
CASE PRESENTATION ON APABAHUKA (FROZEN SHOULDER)
CASE PRESENTATION ON APABAHUKA (FROZEN SHOULDER)CASE PRESENTATION ON APABAHUKA (FROZEN SHOULDER)
CASE PRESENTATION ON APABAHUKA (FROZEN SHOULDER)Dr Kaushal Kumar Sinha
 
Membranous Nephropathy (KDIGO 2021 Guidelines) - Dr. Gawad
Membranous Nephropathy (KDIGO 2021 Guidelines) - Dr. GawadMembranous Nephropathy (KDIGO 2021 Guidelines) - Dr. Gawad
Membranous Nephropathy (KDIGO 2021 Guidelines) - Dr. GawadNephroTube - Dr.Gawad
 
Case study-motor system,myopathy,muscular dystrophy
Case study-motor system,myopathy,muscular dystrophyCase study-motor system,myopathy,muscular dystrophy
Case study-motor system,myopathy,muscular dystrophyapoorvaerukulla
 
Hif ph inhibitors for anemia in ckd
Hif ph inhibitors for anemia in ckdHif ph inhibitors for anemia in ckd
Hif ph inhibitors for anemia in ckdHarsh shaH
 
ANCA vasculitis (KDIGO 2021 Guidelines) - Dr. Gawad
ANCA vasculitis (KDIGO 2021 Guidelines) - Dr. GawadANCA vasculitis (KDIGO 2021 Guidelines) - Dr. Gawad
ANCA vasculitis (KDIGO 2021 Guidelines) - Dr. GawadNephroTube - Dr.Gawad
 
Acute Kidney Injury Management (Volume Replacement) - Dr. Gawad
Acute Kidney Injury Management (Volume Replacement) - Dr. Gawad Acute Kidney Injury Management (Volume Replacement) - Dr. Gawad
Acute Kidney Injury Management (Volume Replacement) - Dr. Gawad NephroTube - Dr.Gawad
 
Renal function tests - a deep insight by rxvichu!
Renal function tests - a deep insight by rxvichu!Renal function tests - a deep insight by rxvichu!
Renal function tests - a deep insight by rxvichu!RxVichuZ
 

Mais procurados (20)

Bph dr mnr
Bph dr mnrBph dr mnr
Bph dr mnr
 
Anemia in Chronic Kidney DIsease
Anemia in Chronic Kidney DIseaseAnemia in Chronic Kidney DIsease
Anemia in Chronic Kidney DIsease
 
Preparation for transplantation (mih)
Preparation for transplantation (mih)Preparation for transplantation (mih)
Preparation for transplantation (mih)
 
Gout Summery Updated 2020 American College Of Rheumatology Guideline
Gout  Summery Updated 2020 American College Of Rheumatology Guideline Gout  Summery Updated 2020 American College Of Rheumatology Guideline
Gout Summery Updated 2020 American College Of Rheumatology Guideline
 
Adequacy hd
Adequacy hdAdequacy hd
Adequacy hd
 
Hepatorenal syndrome
Hepatorenal syndromeHepatorenal syndrome
Hepatorenal syndrome
 
parkinsons disease case presentation in Ayurveda
parkinsons disease case presentation in Ayurveda parkinsons disease case presentation in Ayurveda
parkinsons disease case presentation in Ayurveda
 
Benign Prostatic Hyperplasia (BPH and LUTS)
Benign Prostatic Hyperplasia (BPH and LUTS)Benign Prostatic Hyperplasia (BPH and LUTS)
Benign Prostatic Hyperplasia (BPH and LUTS)
 
Journal club: Is Early Dialysis Better?
Journal club: Is Early Dialysis Better?Journal club: Is Early Dialysis Better?
Journal club: Is Early Dialysis Better?
 
CKD MBD - Think Outside The Box - Case Scenarios Snapshots - Dr. Gawad
CKD MBD - Think Outside The Box - Case Scenarios Snapshots  - Dr. GawadCKD MBD - Think Outside The Box - Case Scenarios Snapshots  - Dr. Gawad
CKD MBD - Think Outside The Box - Case Scenarios Snapshots - Dr. Gawad
 
Physiological Principles of Hemodialysis - Solve the Crosswords - Dr. Gawad
Physiological Principles of Hemodialysis - Solve the Crosswords - Dr. GawadPhysiological Principles of Hemodialysis - Solve the Crosswords - Dr. Gawad
Physiological Principles of Hemodialysis - Solve the Crosswords - Dr. Gawad
 
CASE PRESENTATION ON APABAHUKA (FROZEN SHOULDER)
CASE PRESENTATION ON APABAHUKA (FROZEN SHOULDER)CASE PRESENTATION ON APABAHUKA (FROZEN SHOULDER)
CASE PRESENTATION ON APABAHUKA (FROZEN SHOULDER)
 
Membranous Nephropathy (KDIGO 2021 Guidelines) - Dr. Gawad
Membranous Nephropathy (KDIGO 2021 Guidelines) - Dr. GawadMembranous Nephropathy (KDIGO 2021 Guidelines) - Dr. Gawad
Membranous Nephropathy (KDIGO 2021 Guidelines) - Dr. Gawad
 
Case study-motor system,myopathy,muscular dystrophy
Case study-motor system,myopathy,muscular dystrophyCase study-motor system,myopathy,muscular dystrophy
Case study-motor system,myopathy,muscular dystrophy
 
Hif ph inhibitors for anemia in ckd
Hif ph inhibitors for anemia in ckdHif ph inhibitors for anemia in ckd
Hif ph inhibitors for anemia in ckd
 
ANCA vasculitis (KDIGO 2021 Guidelines) - Dr. Gawad
ANCA vasculitis (KDIGO 2021 Guidelines) - Dr. GawadANCA vasculitis (KDIGO 2021 Guidelines) - Dr. Gawad
ANCA vasculitis (KDIGO 2021 Guidelines) - Dr. Gawad
 
Acute Kidney Injury Management (Volume Replacement) - Dr. Gawad
Acute Kidney Injury Management (Volume Replacement) - Dr. Gawad Acute Kidney Injury Management (Volume Replacement) - Dr. Gawad
Acute Kidney Injury Management (Volume Replacement) - Dr. Gawad
 
Diabetic+Nephropathy
Diabetic+NephropathyDiabetic+Nephropathy
Diabetic+Nephropathy
 
Renal function tests - a deep insight by rxvichu!
Renal function tests - a deep insight by rxvichu!Renal function tests - a deep insight by rxvichu!
Renal function tests - a deep insight by rxvichu!
 
Prostate BPH- pathophysiology
Prostate  BPH- pathophysiologyProstate  BPH- pathophysiology
Prostate BPH- pathophysiology
 

Destaque

End Stage Renal Disease RCP
End Stage Renal Disease RCPEnd Stage Renal Disease RCP
End Stage Renal Disease RCPcschoolmaster
 
Efficacy of Dietary Intervention in END STAGE RENAL DISEASE
Efficacy of Dietary Intervention in END STAGE RENAL DISEASEEfficacy of Dietary Intervention in END STAGE RENAL DISEASE
Efficacy of Dietary Intervention in END STAGE RENAL DISEASEJunaid Nazar
 
Aims, Objective, Concept of Screening
Aims, Objective, Concept of ScreeningAims, Objective, Concept of Screening
Aims, Objective, Concept of ScreeningDr. Abraham Mallela
 
Microalbuminuria in simple way
Microalbuminuria in simple way Microalbuminuria in simple way
Microalbuminuria in simple way Y Alsfah
 
Chronic Renal Disease (CKD)
Chronic Renal Disease (CKD)Chronic Renal Disease (CKD)
Chronic Renal Disease (CKD)Janelyn Ong
 
Microalbuminuria
MicroalbuminuriaMicroalbuminuria
Microalbuminuriamondy19
 
Common presentation and investigation of Kidney diseases
Common presentation and investigation of Kidney diseasesCommon presentation and investigation of Kidney diseases
Common presentation and investigation of Kidney diseasesEzmeer Emiral
 
Clinical presentation of renal disease
Clinical presentation of renal diseaseClinical presentation of renal disease
Clinical presentation of renal diseaseThilak Jayalath
 
Causation in epidemiology
Causation in epidemiologyCausation in epidemiology
Causation in epidemiologySoyebo Oluseye
 
Renal disorders and their dental management
Renal disorders and their dental managementRenal disorders and their dental management
Renal disorders and their dental managementDivya Rana
 
Concept of disease causation
Concept of disease causationConcept of disease causation
Concept of disease causationRizwan S A
 
23 renal disease
23 renal disease23 renal disease
23 renal diseaseinternalmed
 
association and causation
association and causationassociation and causation
association and causationguestc43c63
 

Destaque (20)

Uses of Screening
Uses of ScreeningUses of Screening
Uses of Screening
 
Supra Rx Dose of ARBs
Supra Rx Dose of ARBsSupra Rx Dose of ARBs
Supra Rx Dose of ARBs
 
Periodic health examination
Periodic health examinationPeriodic health examination
Periodic health examination
 
End Stage Renal Disease RCP
End Stage Renal Disease RCPEnd Stage Renal Disease RCP
End Stage Renal Disease RCP
 
Efficacy of Dietary Intervention in END STAGE RENAL DISEASE
Efficacy of Dietary Intervention in END STAGE RENAL DISEASEEfficacy of Dietary Intervention in END STAGE RENAL DISEASE
Efficacy of Dietary Intervention in END STAGE RENAL DISEASE
 
Aims, Objective, Concept of Screening
Aims, Objective, Concept of ScreeningAims, Objective, Concept of Screening
Aims, Objective, Concept of Screening
 
Microalbuminuria in simple way
Microalbuminuria in simple way Microalbuminuria in simple way
Microalbuminuria in simple way
 
Chronic Renal Disease (CKD)
Chronic Renal Disease (CKD)Chronic Renal Disease (CKD)
Chronic Renal Disease (CKD)
 
Microalbuminuria
MicroalbuminuriaMicroalbuminuria
Microalbuminuria
 
Common presentation and investigation of Kidney diseases
Common presentation and investigation of Kidney diseasesCommon presentation and investigation of Kidney diseases
Common presentation and investigation of Kidney diseases
 
Clinical presentation of renal disease
Clinical presentation of renal diseaseClinical presentation of renal disease
Clinical presentation of renal disease
 
Types of Screening
Types of ScreeningTypes of Screening
Types of Screening
 
Causation in epidemiology
Causation in epidemiologyCausation in epidemiology
Causation in epidemiology
 
Screening
ScreeningScreening
Screening
 
Renal disorders and their dental management
Renal disorders and their dental managementRenal disorders and their dental management
Renal disorders and their dental management
 
Concept of disease causation
Concept of disease causationConcept of disease causation
Concept of disease causation
 
پریا امیرپور
پریا امیرپورپریا امیرپور
پریا امیرپور
 
23 renal disease
23 renal disease23 renal disease
23 renal disease
 
association and causation
association and causationassociation and causation
association and causation
 
Chronic renal failure
Chronic renal failure Chronic renal failure
Chronic renal failure
 

Semelhante a Screening

Asymptomatic Microscopic Hemature : 2012 AUA Guidelines
Asymptomatic Microscopic Hemature : 2012 AUA GuidelinesAsymptomatic Microscopic Hemature : 2012 AUA Guidelines
Asymptomatic Microscopic Hemature : 2012 AUA GuidelinesRIAPA
 
Acute Pancreatitis Managment
Acute Pancreatitis ManagmentAcute Pancreatitis Managment
Acute Pancreatitis ManagmentNouman Memon
 
Acute Pancreatitis Management Conference
Acute Pancreatitis Management ConferenceAcute Pancreatitis Management Conference
Acute Pancreatitis Management Conferencejcm MD
 
Liver Cirrhosis Plus
Liver Cirrhosis PlusLiver Cirrhosis Plus
Liver Cirrhosis PlusShaikhani.
 
Index tb guideline eptb final2
Index tb guideline  eptb final2Index tb guideline  eptb final2
Index tb guideline eptb final2Dr.Akhilesh kunoor
 
INDEX TB GUIDELINE - EXTRA PULMONARY TB
INDEX TB GUIDELINE - EXTRA PULMONARY TBINDEX TB GUIDELINE - EXTRA PULMONARY TB
INDEX TB GUIDELINE - EXTRA PULMONARY TBDr.Akhilesh kunoor
 
Guidelines for the investigation of chronic diarrhoea in
Guidelines for the investigation of chronic diarrhoea inGuidelines for the investigation of chronic diarrhoea in
Guidelines for the investigation of chronic diarrhoea inDev Prashad
 
AKI Lecture 2010
AKI Lecture 2010AKI Lecture 2010
AKI Lecture 2010Joel Topf
 
Family Physician's Approach to Elevated PSA
Family Physician's Approach to Elevated PSAFamily Physician's Approach to Elevated PSA
Family Physician's Approach to Elevated PSASiewhong Ho
 
Mon 8-00 Prostate Cancer Screening in the Post-USPSTF Era_0.pptx
Mon 8-00   Prostate Cancer Screening in the Post-USPSTF Era_0.pptxMon 8-00   Prostate Cancer Screening in the Post-USPSTF Era_0.pptx
Mon 8-00 Prostate Cancer Screening in the Post-USPSTF Era_0.pptxRonitEnterprises
 
Prostate diseases for General practitioners
Prostate diseases for General practitionersProstate diseases for General practitioners
Prostate diseases for General practitionersPriyatham Kasaraneni
 
Overview of the, clinicianb
Overview of the, clinicianbOverview of the, clinicianb
Overview of the, clinicianbNwankwo Henry
 
Sat 0855-hepatitis-c-update- -park
Sat 0855-hepatitis-c-update- -parkSat 0855-hepatitis-c-update- -park
Sat 0855-hepatitis-c-update- -parkIhsaan Peer
 
Acute Renal Failure Lecture
Acute Renal Failure LectureAcute Renal Failure Lecture
Acute Renal Failure LectureJoel Topf
 
benign prostatic hyperplasia by dr.bagasi
benign prostatic hyperplasia by dr.bagasibenign prostatic hyperplasia by dr.bagasi
benign prostatic hyperplasia by dr.bagasiAbdulaziz Bagasi
 

Semelhante a Screening (20)

Asymptomatic Microscopic Hemature : 2012 AUA Guidelines
Asymptomatic Microscopic Hemature : 2012 AUA GuidelinesAsymptomatic Microscopic Hemature : 2012 AUA Guidelines
Asymptomatic Microscopic Hemature : 2012 AUA Guidelines
 
A Case of ANCA Vasculitis
A Case of ANCA VasculitisA Case of ANCA Vasculitis
A Case of ANCA Vasculitis
 
Acute Pancreatitis Managment
Acute Pancreatitis ManagmentAcute Pancreatitis Managment
Acute Pancreatitis Managment
 
Acute Pancreatitis Management Conference
Acute Pancreatitis Management ConferenceAcute Pancreatitis Management Conference
Acute Pancreatitis Management Conference
 
Liver Cirrhosis Plus
Liver Cirrhosis PlusLiver Cirrhosis Plus
Liver Cirrhosis Plus
 
Index tb guideline eptb final2
Index tb guideline  eptb final2Index tb guideline  eptb final2
Index tb guideline eptb final2
 
INDEX TB GUIDELINE - EXTRA PULMONARY TB
INDEX TB GUIDELINE - EXTRA PULMONARY TBINDEX TB GUIDELINE - EXTRA PULMONARY TB
INDEX TB GUIDELINE - EXTRA PULMONARY TB
 
Guidelines for the investigation of chronic diarrhoea in
Guidelines for the investigation of chronic diarrhoea inGuidelines for the investigation of chronic diarrhoea in
Guidelines for the investigation of chronic diarrhoea in
 
Calling Primary Care Partners to Action in Hypertrophic Cardiomyopathy: Short...
Calling Primary Care Partners to Action in Hypertrophic Cardiomyopathy: Short...Calling Primary Care Partners to Action in Hypertrophic Cardiomyopathy: Short...
Calling Primary Care Partners to Action in Hypertrophic Cardiomyopathy: Short...
 
AKI Lecture 2010
AKI Lecture 2010AKI Lecture 2010
AKI Lecture 2010
 
Family Physician's Approach to Elevated PSA
Family Physician's Approach to Elevated PSAFamily Physician's Approach to Elevated PSA
Family Physician's Approach to Elevated PSA
 
Mon 8-00 Prostate Cancer Screening in the Post-USPSTF Era_0.pptx
Mon 8-00   Prostate Cancer Screening in the Post-USPSTF Era_0.pptxMon 8-00   Prostate Cancer Screening in the Post-USPSTF Era_0.pptx
Mon 8-00 Prostate Cancer Screening in the Post-USPSTF Era_0.pptx
 
NAFLD
NAFLDNAFLD
NAFLD
 
Prostate diseases for General practitioners
Prostate diseases for General practitionersProstate diseases for General practitioners
Prostate diseases for General practitioners
 
MCC 2011 - Slide 22
MCC 2011 - Slide 22MCC 2011 - Slide 22
MCC 2011 - Slide 22
 
Overview of the, clinicianb
Overview of the, clinicianbOverview of the, clinicianb
Overview of the, clinicianb
 
Renal Emergencies
Renal EmergenciesRenal Emergencies
Renal Emergencies
 
Sat 0855-hepatitis-c-update- -park
Sat 0855-hepatitis-c-update- -parkSat 0855-hepatitis-c-update- -park
Sat 0855-hepatitis-c-update- -park
 
Acute Renal Failure Lecture
Acute Renal Failure LectureAcute Renal Failure Lecture
Acute Renal Failure Lecture
 
benign prostatic hyperplasia by dr.bagasi
benign prostatic hyperplasia by dr.bagasibenign prostatic hyperplasia by dr.bagasi
benign prostatic hyperplasia by dr.bagasi
 

Mais de edwinchowyw

Focal Glomerulosclerosis
Focal GlomerulosclerosisFocal Glomerulosclerosis
Focal Glomerulosclerosisedwinchowyw
 
Tubulointerstitial diseases
Tubulointerstitial diseasesTubulointerstitial diseases
Tubulointerstitial diseasesedwinchowyw
 
Minimal Light Microscopic Changes
Minimal Light Microscopic ChangesMinimal Light Microscopic Changes
Minimal Light Microscopic Changesedwinchowyw
 
Diffuse Proliferative GN
Diffuse Proliferative GNDiffuse Proliferative GN
Diffuse Proliferative GNedwinchowyw
 
Mesangial proliferative GN
Mesangial proliferative GNMesangial proliferative GN
Mesangial proliferative GNedwinchowyw
 
Focalproliferative Glomerulonephritis
Focalproliferative GlomerulonephritisFocalproliferative Glomerulonephritis
Focalproliferative Glomerulonephritisedwinchowyw
 
Basement Membrane Abnormalities
Basement Membrane AbnormalitiesBasement Membrane Abnormalities
Basement Membrane Abnormalitiesedwinchowyw
 
Humoral Immunity
Humoral ImmunityHumoral Immunity
Humoral Immunityedwinchowyw
 
Introduction to Renal Pathology
Introduction to Renal PathologyIntroduction to Renal Pathology
Introduction to Renal Pathologyedwinchowyw
 
Nephrotic Syndrome
Nephrotic SyndromeNephrotic Syndrome
Nephrotic Syndromeedwinchowyw
 
Dry Weight Dr Rosna
Dry Weight Dr RosnaDry Weight Dr Rosna
Dry Weight Dr Rosnaedwinchowyw
 
Bartter’S And Gittleman’S Syndromes
Bartter’S And Gittleman’S SyndromesBartter’S And Gittleman’S Syndromes
Bartter’S And Gittleman’S Syndromesedwinchowyw
 
Mycophenolate Mofetil in Primary Glomerulonephritis
Mycophenolate Mofetil in Primary GlomerulonephritisMycophenolate Mofetil in Primary Glomerulonephritis
Mycophenolate Mofetil in Primary Glomerulonephritisedwinchowyw
 
Mycophenolate Mofetil In Relapsing Lupus Nephritis
Mycophenolate Mofetil In Relapsing Lupus NephritisMycophenolate Mofetil In Relapsing Lupus Nephritis
Mycophenolate Mofetil In Relapsing Lupus Nephritisedwinchowyw
 
Globalwarmingshow
GlobalwarmingshowGlobalwarmingshow
Globalwarmingshowedwinchowyw
 

Mais de edwinchowyw (20)

Focal Glomerulosclerosis
Focal GlomerulosclerosisFocal Glomerulosclerosis
Focal Glomerulosclerosis
 
MPGN/MCGN
MPGN/MCGNMPGN/MCGN
MPGN/MCGN
 
Membranous GN
Membranous GNMembranous GN
Membranous GN
 
Nodular GN
Nodular GNNodular GN
Nodular GN
 
Tubulointerstitial diseases
Tubulointerstitial diseasesTubulointerstitial diseases
Tubulointerstitial diseases
 
Minimal Light Microscopic Changes
Minimal Light Microscopic ChangesMinimal Light Microscopic Changes
Minimal Light Microscopic Changes
 
Crescentic GN
Crescentic GNCrescentic GN
Crescentic GN
 
Diffuse Proliferative GN
Diffuse Proliferative GNDiffuse Proliferative GN
Diffuse Proliferative GN
 
Mesangial proliferative GN
Mesangial proliferative GNMesangial proliferative GN
Mesangial proliferative GN
 
Focalproliferative Glomerulonephritis
Focalproliferative GlomerulonephritisFocalproliferative Glomerulonephritis
Focalproliferative Glomerulonephritis
 
Basement Membrane Abnormalities
Basement Membrane AbnormalitiesBasement Membrane Abnormalities
Basement Membrane Abnormalities
 
Humoral Immunity
Humoral ImmunityHumoral Immunity
Humoral Immunity
 
Introduction to Renal Pathology
Introduction to Renal PathologyIntroduction to Renal Pathology
Introduction to Renal Pathology
 
Intro Immune
Intro ImmuneIntro Immune
Intro Immune
 
Nephrotic Syndrome
Nephrotic SyndromeNephrotic Syndrome
Nephrotic Syndrome
 
Dry Weight Dr Rosna
Dry Weight Dr RosnaDry Weight Dr Rosna
Dry Weight Dr Rosna
 
Bartter’S And Gittleman’S Syndromes
Bartter’S And Gittleman’S SyndromesBartter’S And Gittleman’S Syndromes
Bartter’S And Gittleman’S Syndromes
 
Mycophenolate Mofetil in Primary Glomerulonephritis
Mycophenolate Mofetil in Primary GlomerulonephritisMycophenolate Mofetil in Primary Glomerulonephritis
Mycophenolate Mofetil in Primary Glomerulonephritis
 
Mycophenolate Mofetil In Relapsing Lupus Nephritis
Mycophenolate Mofetil In Relapsing Lupus NephritisMycophenolate Mofetil In Relapsing Lupus Nephritis
Mycophenolate Mofetil In Relapsing Lupus Nephritis
 
Globalwarmingshow
GlobalwarmingshowGlobalwarmingshow
Globalwarmingshow
 

Último

SWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.pptSWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.pptMumux Mirani
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdfDolisha Warbi
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPrerana Jadhav
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Prerana Jadhav
 
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfPULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfDolisha Warbi
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxDr. Dheeraj Kumar
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxSasikiranMarri
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranTara Rajendran
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfDivya Kanojiya
 
world health day presentation ppt download
world health day presentation ppt downloadworld health day presentation ppt download
world health day presentation ppt downloadAnkitKumar311566
 
Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?bkling
 
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...saminamagar
 
See the 2,456 pharmacies on the National E-Pharmacy Platform
See the 2,456 pharmacies on the National E-Pharmacy PlatformSee the 2,456 pharmacies on the National E-Pharmacy Platform
See the 2,456 pharmacies on the National E-Pharmacy PlatformKweku Zurek
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Mohamed Rizk Khodair
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiGoogle
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxdrashraf369
 
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️saminamagar
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxNiranjan Chavan
 
Report Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptxReport Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptxbkling
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfSasikiranMarri
 

Último (20)

SWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.pptSWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.ppt
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous System
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.
 
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfPULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptx
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptx
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdf
 
world health day presentation ppt download
world health day presentation ppt downloadworld health day presentation ppt download
world health day presentation ppt download
 
Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?
 
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...
 
See the 2,456 pharmacies on the National E-Pharmacy Platform
See the 2,456 pharmacies on the National E-Pharmacy PlatformSee the 2,456 pharmacies on the National E-Pharmacy Platform
See the 2,456 pharmacies on the National E-Pharmacy Platform
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali Rai
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
 
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptx
 
Report Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptxReport Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptx
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdf
 

Screening

  • 1. Early Detection Of Renal Disease
  • 2.
  • 3.
  • 4.
  • 5. Relationship between serum creatinine and GFR
  • 6. 1.23 x (140-Age) x BW Sr Cr (umol/l) 1.04 x (140-Age) x BW Sr Cr (umol/l) Estimated Glomerular Filtration rate Man Woman Screening method Estimated GFR
  • 7.
  • 8. Screening methods Microalbuminuria testing
  • 9.
  • 10.
  • 11. Screening of renal disease : Hypertensive patients UFEME BUSE/Cr USS KUB Other test Young hypertensive Yearly Yearly UFEME BUSE/Cr All hypertensive Frequency Screening tests
  • 12.
  • 13. Urine dipstick for protein Positive (Urine protein >300mg/l) On 2 separate occasions (exclude other causes) Overt Nephropathy Quantify excretion rate 24HUP Negative Screen for Microalbuminuria (on early morning spot urine) Negative Yearly test Positive Retest twice in 3-6/12 Exclude other cause If 2 of test are positive Diagnosis of microalbuminuria Is established 3-6 monthly follow-up of microalbuminuria Optimise glycaemic control Strict Bp control ACE/ARB Stop smoking Lifestyle modification Treat hyperlipidaemia Avoid excessive protein intake Monitor renal function Monitor other endorgan damage Algorithm: Screening for proteinuria/microalbuminuria in DM
  • 14. Proteinuria is a major manifestation of renal disease Screening of renal disease Proteinuria <20 <30 Normoalbuminuria >35 women >25 men >200 >200 >300 Overt Proteinuria 3.5-35 women 2.5-25 men 20-200 20-200 30-300 Microalbuminuria Urine Albumin:creatinine ratio (mg/mmol) Urine Albumin Concentration (mg/l) <3.5 women <2.5 men <20 First voided morning specimen Timed Collection (ug/min) 24 hr Collection (mg/24h) Specimen collected Albumin Excretion
  • 15.
  • 16.
  • 17. History Physical Examination Urine Examination of Urinary sediment Abnorma l refer to a nephrologist Normal Repeat visit for a Qualitative proteinuria test Positive Do Renal profile Quantitate urinary protein Refer to nephrologist Negative Transient proteinuria Reassure Evaluation of persistent proteinuria
  • 18.
  • 19.
  • 20.
  • 21.
  • 22.
  • 23. Studies on Early vs late referral AV access use at initiation of HD increased with earlier referral time 499 ER < 1 mo LR > 12 mo USA 1995-1998 CHOICE study LR > ER 78 106 ER > 3 mo LR < 1 mo Brazil 1992-1995 Sesso et al LR > ER 2264 ER > 4 mo LR < 4 mo Texas 2002 Stack et al LR > ER 325 325 ER > 4 mo LR < 4 mo Edinburgh 1987-1992 Eadington et al LR > ER 153 65 ER > 6 mo LR < 1 mo Paris 1989-1991 Jungers et al LR > ER 32 23 ER > 1 mo LR < 1 mo Oxford 1981 Ratcliffe et al Mortality risk Mean length of hospital stay (days) No of patients Timing of referral Location/ year Source